Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)

Hyundai Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	498,921	561,851	1,038,982	1,087,244	976,101	1,048,678
Market Cap Growth	-45.92%	-45.92%	-4.44%	11.39%	-6.92%	115.45%
Enterprise Value	521,858	579,143	1,031,571	1,069,527	969,321	1,050,097
Last Close Price	10390.00	14110.00	24591.94	25816.83	23791.06	27512.82
PS Ratio	27.49	37.33	109.58	138.48	105.62	83.82
PB Ratio	10.49	14.25	22.95	18.67	15.85	20.04
P/TBV Ratio	89.63	89.63	73.68	43.38	34.98	81.02
P/FCF Ratio	239.01	269.15	-	-	-	-
P/OCF Ratio	248.93	248.93	-	-	-	139.79
EV/Sales Ratio	34.67	38.48	108.80	136.22	104.89	83.93
EV/EBITDA Ratio	406.48	406.48	-	-	-	-
EV/EBIT Ratio	732.19	732.19	-	-	-	-
EV/FCF Ratio	249.99	277.44	-	-	-	-
Debt / Equity Ratio	0.67	0.67	0.12	0.11	0.25	0.71
Debt / EBITDA Ratio	18.66	18.66	-	-	-	-
Debt / FCF Ratio	12.74	12.74	-	-	-	-
Asset Turnover	0.25	0.25	0.16	0.11	0.11	0.16
Inventory Turnover	1.78	1.78	1.62	1.63	1.59	1.19
Quick Ratio	0.14	0.14	1.77	2.23	1.73	3.41
Current Ratio	0.25	0.25	2.18	2.67	2.02	4.37
Return on Equity (ROE)	-16.36%	-16.36%	-28.02%	-26.39%	-35.21%	-16.50%
Return on Assets (ROA)	0.82%	0.82%	-10.20%	-22.24%	-6.66%	-3.51%
Return on Capital (ROIC)	0.85%	0.85%	-10.63%	-23.24%	-6.97%	-3.67%
Return on Capital Employed (ROCE)	2.00%	2.00%	-	-	-	-
Earnings Yield	-1.39%	-1.23%	-1.40%	-1.45%	-2.05%	-0.79%
FCF Yield	0.42%	0.37%	-0.63%	-1.66%	-0.44%	-1.69%
Buyback Yield / Dilution	-0.25%	-0.25%	-0.91%	-6.64%	-2.79%	-3.67%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.